WallStreetZenWallStreetZen

NASDAQ: PBLA
Panbela Therapeutics Inc Stock

Open Broker Account
$0.27-0.09 (-25%)
Updated Sep 30, 2022
Panbela Therapeutics shares are trading... find out Why PBLA Price Moved with a free WallStreetZen account
Why Price Moved
PBLA Price
$0.27
Fair Value Price
$0.44
Market Cap
$3.63M
52 Week Low
$0.20
52 Week High
$2.40
P/E
-0.12x
P/B
-0.75x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$31.48M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-2.36
Operating Cash Flow
-$12M
Beta
0.28
Next Earnings
Nov 8, 2022
Ex-Dividend
N/A
Next Dividend
N/A

Zen Score

Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how PBLA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

PBLA ($0.27) is undervalued by 39.04% relative to our estimate of its Fair Value price of $0.44 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
PBLA ($0.27) is significantly undervalued by 39.04% relative to our estimate of its Fair Value price of $0.44 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
PBLA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more PBLA due diligence checks available for Premium users.

Be the first to know about important PBLA news, forecast changes, insider trades & much more!

PBLA News

Valuation

PBLA fair value

Fair Value of PBLA stock based on Discounted Cash Flow (DCF)
Price
$0.27
Fair Value
$0.44
Undervalued by
39.04%
PBLA ($0.27) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
PBLA ($0.27) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
PBLA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

PBLA price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.12x
Industry
14.28x
Market
27.64x

PBLA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-0.75x
Industry
4.39x

PBLA's financial health

Profit margin

Revenue
$0.0
Net Income
-$22.1M
Profit Margin
0%
PBLA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$6.6M
Liabilities
$11.4M
Debt to equity
-2.36
PBLA's short-term liabilities ($6.20M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PBLA's long-term liabilities ($5.19M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PBLA's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
PBLA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$4.2M
Investing
$0.0
Financing
$0.0
PBLA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

PBLA vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
PBLA$3.63M-24.79%-0.12x-0.75x
ADTX$3.85M+0.30%-0.04x2.83x
HSTO$3.37M-4.93%-0.27x0.21x
ANPC$4.06M-8.93%-0.14x3.32x
VIRI$3.17M+4.10%-0.19x0.44x

Panbela Therapeutics Stock FAQ

What is Panbela Therapeutics's quote symbol?

NASDAQ: PBLA) Panbela Therapeutics trades on the NASDAQ under the ticker symbol PBLA. Panbela Therapeutics stock quotes can also be displayed as NASDAQ: PBLA.

If you're new to stock investing, here's how to buy Panbela Therapeutics stock.

What is the 52 week high and low for Panbela Therapeutics (NASDAQ: PBLA)?

(NASDAQ: PBLA) Panbela Therapeutics's 52-week high was $2.40, and its 52-week low was $0.20. It is currently -88.75% from its 52-week high and 33% from its 52-week low.

How much is Panbela Therapeutics stock worth today?

(NASDAQ: PBLA) Panbela Therapeutics currently has 13,443,722 outstanding shares. With Panbela Therapeutics stock trading at $0.27 per share, the total value of Panbela Therapeutics stock (market capitalization) is $3.63M.

Panbela Therapeutics stock was originally listed at a price of $3.09 in Aug 31, 2020. If you had invested in Panbela Therapeutics stock at $3.09, your return over the last 2 years would have been -91.26%, for an annualized return of -70.44% (not including any dividends or dividend reinvestments).

How much is Panbela Therapeutics's stock price per share?

(NASDAQ: PBLA) Panbela Therapeutics stock price per share is $0.27 today (as of Sep 30, 2022).

What is Panbela Therapeutics's Market Cap?

(NASDAQ: PBLA) Panbela Therapeutics's market cap is $3.63M, as of Oct 2, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Panbela Therapeutics's market cap is calculated by multiplying PBLA's current stock price of $0.27 by PBLA's total outstanding shares of 13,443,722.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.